Beckmann Matthias W, Lotz Laura, Toth Bettina, Baston-Büst Dunja Maria, Fehm Tanja, Frambach Torsten, Germeyer Ariane, Goeckenjan Maren, Häberlin Felix, Henes Melanie, Hirchenhain Jens, Hübner Stephanie, Korell Matthias, Krüssel Jan-Steffen, Müller Andreas, Reinsberg Jochen, Schwab Roxana, Seitz Stephan, Sütterlin Marc, van der Ven Hans, van der Ven Katrin, Winkler-Crepaz Katharina, Wimberger Pauline, von Wolff Michael, Liebenthron Jana, Dittrich Ralf
Frauenklinik, Universitätsklinikum Erlangen, Erlangen, Germany.
Gynäkologische Endokrinologie und Reproduktionsmedizin, Universitätsklinikum Innsbruck, Innsbruck, Austria.
Geburtshilfe Frauenheilkd. 2019 Jan;79(1):53-62. doi: 10.1055/a-0664-8619. Epub 2018 Oct 9.
The cryopreservation of ovarian tissue with subsequent transplantation of the tissue represents an established method of fertility protection for female patients who have to undergo gonadotoxic therapy. The procedure can be performed at any point in the cycle and thus generally does not lead to any delay in oncological therapy. With the aid of this procedure, more than 130 births to date worldwide have been able to be recorded. The birth rate is currently approximately 30% and it can be assumed that this will increase through the further optimisation of the cryopreservation and surgical technique. The concept paper presented here is intended to provide guidance for managing cryopreservation and transplantation of ovarian tissue to German-speaking reproductive medicine centres.
对卵巢组织进行冷冻保存并随后移植该组织,是一种为必须接受性腺毒性治疗的女性患者提供生育保护的既定方法。该手术可在月经周期的任何时间进行,因此一般不会导致肿瘤治疗的任何延迟。借助这一手术,迄今为止全球已记录到130多例分娩。目前的出生率约为30%,可以设想,通过进一步优化冷冻保存和手术技术,这一数字将会上升。本文提出的概念文件旨在为德语区生殖医学中心管理卵巢组织冷冻保存和移植提供指导。